May Hill Capital’s GSK GSK Stock Holding History

May Hill Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$549K	Buy	9,944 +1,764	+22%	+$95.6K	0.14%	101
2025 Q4	$401K	Buy	8,180 +256	+3%	+$11.9K	0.11%	124
2025 Q3	$342K	Sell	7,924 -1,999	-20%	-$78.1K	0.1%	132
2025 Q2	$381K	Buy	9,923 +514	+5%	+$19.6K	0.13%	115
2025 Q1	$365K	Buy	+9,409	New	+$344K	0.14%	109

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

May Hill Capital's GSK Position: Q1 2026 in Review

May Hill Capital increased its GSK (GSK) stake by 22% in Q1 2026, buying an estimated $95.6K and bringing the position to 9,944 shares worth $549K. The position accounts for 0.14% of the portfolio, ranked #101.

May Hill Capital first reported a position in GSK in Q1 2025 and has held it in 5 quarters since. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

May Hill Capital held 9,944 shares of GSK worth $549K as of Q1 2026.
May Hill Capital bought 1,764 GSK shares in Q1 2026, an estimated $95.6K.
GSK made up 0.14% of May Hill Capital's portfolio in Q1 2026, its #101 holding.
May Hill Capital first reported a position in GSK in Q1 2025 and has held it in 5 quarters since.
1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on May Hill Capital's 13F filing for Q1 2026, filed 6 May 2026.